Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company pioneering novel cancer therapies, announced that it has completed enrollment in the phase 3 SENTRY trial, which is evaluating ...

There is pressing need for third-party, tech-enabled training to enforcement agencies: BDCDA: Nandita Vijayasimha, Bengaluru ...

PCI once again opens portal for institutes to submit additional information for approval: Gireesh Babu, New Delhi Thursday, ...

US FDA grants fast track designation to Greenwich LifeSciences’ GLSI-100 in the HLA-A*02 patient population: Stafford, Texas Thursday, September 11, 2025, 16:00 Hrs [IST] Greenw ...

Our Bureau, Mumbai Thursday, September 11, 2025, 16:30 Hrs [IST] ...

Biocon, an innovation-led global biopharmaceutical company, announced the inauguration of its first US manufacturing facility in Cranbury, New Jersey, by its wholly owned subsidiary, Biocon Generics ...

IIT Kanpur researchers develop novel sensor to study how medicines activate vital receptors: Our Bureau, Mumbai Thursday, September 11, 2025, 16:15 Hrs [IST] Researchers at the In ...

Apollo MD calls healthcare and medical tourism India’s next engines of services-led growth: Our Bureau, Bengaluru Thursday, September 11, 2025, 14:30 Hrs [IST] Suneeta Reddy, pr ...

Sanofi to present new data from 14 abstracts across multiple sclerosis at ECTRIMS 2025 congress in Barcelona, Spain: Paris Thursday, September 11, 2025, 13:00 Hrs [IST] New data f ...

Galderma introduces Alastin in China, supporting the skin’s natural regenerative abilities in a rapidly expanding market: Zug, Switzerland Thursday, September 11, 2025, 14:00 Hr ...

Chinese NMPA approves Sanofi’s Tzield as first disease-modifying therapy for adult and paediatric patients with stage 2 type 1 diabetes: Paris Thursday, September 11, 2025, 09:0 ...

Rainbow Children’s Medicare expands Andhra Pradesh footprint with 100-bed greenfield hospital in Rajahmundry: Our Bureau, Bengaluru Thursday, September 11, 2025, 14:15 Hrs [IST] ...